$RGBP Regen BioPharma, Inc. Examines Combining
Post# of 42111
$RGBP Regen BioPharma, Inc. Examines Combining Cannabidiol (CBD) With Its Lead NR2F6 Agonist To Treat for Inflammatory Bowel Disease
https://finance.yahoo.com/news/regen-biopharm...00199.html